{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:48:56Z","timestamp":1740142136853,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011482","name":"Yantai Science and Technology Bureau","doi-asserted-by":"publisher","award":["NO.2021MSGY043"],"award-info":[{"award-number":["NO.2021MSGY043"]}],"id":[{"id":"10.13039\/501100011482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["NO.ZR2022MH297"],"award-info":[{"award-number":["NO.ZR2022MH297"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00795-024-00398-9","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:02:13Z","timestamp":1721127733000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nodal T follicular helper cell lymphoma with aberrant CD20 expression and monoclonal TCR, IG rearrangements secondary to Classical Hodgkin Lymphoma: a case report"],"prefix":"10.1007","volume":"57","author":[{"given":"Ning","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1381-2590","authenticated-orcid":false,"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"398_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1515\/med-2020-0191","volume":"15","author":"W Gui","year":"2020","unstructured":"Gui W, Wang J, Ma L, Wang YL, Su LP (2020) Clinicopathological analysis of composite lymphoma: a two-case report and literature review. Open Med (Wars) 15:654\u2013658","journal-title":"Open Med (Wars)"},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1631\/jzus.B2300181","volume":"24","author":"XL Jin","year":"2023","unstructured":"Jin XL, Liu H, Li J, Xiao XB, Yuan XG, Chen PP, Chen BX, Liang Y, Huang FB (2023) Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review. J Zhejiang Univ Sci B 24:711\u2013722","journal-title":"J Zhejiang Univ Sci B"},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"1611051","DOI":"10.3389\/pore.2023.1611051","volume":"29","author":"HY Wang","year":"2023","unstructured":"Wang HY, Yang LQ, Li QY, Song HY, Ji H (2023) Case report: composite mantle cell lymphoma and classical Hodgkin lymphoma. Pathol Oncol Res 29:1611051","journal-title":"Pathol Oncol Res"},{"key":"398_CR4","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.5001\/omj.2023.13","volume":"38","author":"L Abraham","year":"2023","unstructured":"Abraham L, Paul M, Varghese D, D\u2019Souza C (2023) A rare case of metachronous peripheral T-cell non-Hodgkin lymphoma following Epstein-Barr virus-positive diffuse large B-cell lymphoma. Not Otherwise Specified Oman Med J 38:e487","journal-title":"Not Otherwise Specified Oman Med J"},{"key":"398_CR5","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","volume":"15","author":"R K\u00fcppers","year":"2014","unstructured":"K\u00fcppers R, D\u00fchrsen U, Hansmann M (2014) Pathogenesis, diagnosis, and treatment of composite lymphomas. Lancet Oncol 15:e435-446","journal-title":"Lancet Oncol"},{"key":"398_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bjh.12980","volume":"166","author":"O Morales","year":"2014","unstructured":"Morales O, Mrizak D, Fran\u00e7ois V, Mustapha R, Miroux C, Depil S, Decouvelaere A, Lionne-Huyghe P, Auriault C, de Launoit Y, Pancr\u00e9 V, Delhem N (2014) Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients. Br J Haematol 166:875\u2013890","journal-title":"Br J Haematol"},{"key":"398_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/pin.12515","volume":"67","author":"A Ichikawa","year":"2017","unstructured":"Ichikawa A, Miyoshi H, Yamauchi T, Arakawa F, Kawano R, Muta H, Sugita Y, Akashi K, Ohshima K (2017) Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis. Pathol Int 67:194\u2013201","journal-title":"Pathol Int"},{"key":"398_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12185-015-1841-x","volume":"102","author":"Y Kakinoki","year":"2015","unstructured":"Kakinoki Y, Hashiguchi J, Ishio T, Chiba K, Niino D, Ohshima K (2015) CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review. Int J Hematol 102:702\u2013708","journal-title":"Int J Hematol"},{"key":"398_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00428-020-02776-x","volume":"477","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen S, Wei R, Guo X, Yang X, Cao Q, Yang Y, Yun J (2020) CD20-positive extranodal NK\/T cell lymphoma: clinicopathologic and prognostic features. Virchows Arch 477:873\u2013883","journal-title":"Virchows Arch"},{"key":"398_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10060341","author":"A Mangogna","year":"2020","unstructured":"Mangogna A, Cox MC, Ruco L, Lopez G, Belmonte B, Di Napoli A (2020) Rituximab plus chemotherapy provides no clinical benefit in a peripheral T-cell lymphoma not otherwise specified with aberrant expression of CD20 and CD79a: a case report and review of the literature. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics10060341","journal-title":"Diagnostics"},{"key":"398_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ajcp\/106.1.78","volume":"106","author":"KM Algino","year":"1996","unstructured":"Algino KM, Thomason RW, King DE, Montiel MM, Craig FE (1996) CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. Am J Clin Pathol 106:78\u201381","journal-title":"Am J Clin Pathol"},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ajcp\/102.4.483","volume":"102","author":"L Quintanilla-Martinez","year":"1994","unstructured":"Quintanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL (1994) CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 102:483\u2013489","journal-title":"Am J Clin Pathol"},{"key":"398_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.leu.2404481","volume":"21","author":"M Br\u00fcggemann","year":"2007","unstructured":"Br\u00fcggemann M, White H, Gaulard P, Garcia-Sanz R, Gameiro P, Oeschger S, Jasani B, Ott M, Delsol G, Orfao A, Tiemann M, Herbst H, Langerak AW, Spaargaren M, Moreau E, Groenen PJ, Sambade C, Foroni L, Carter GI, Hummel M, Bastard C, Davi F, Delfau-Larue MH, Kneba M, van Dongen JJ, Beldjord K, Molina TJ (2007) Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies report of the BIOMED-2 concerted action BHM4 CT98-3936. Leukemia 21:215\u2013221","journal-title":"Leukemia"},{"key":"398_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2353\/jmoldx.2008.080054","volume":"10","author":"BT Tan","year":"2008","unstructured":"Tan BT, Seo K, Warnke RA, Arber DA (2008) The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas. J Mol Diagn 10:502\u2013512","journal-title":"J Mol Diagn"},{"key":"398_CR15","first-page":"2227","volume":"58","author":"K Teshima","year":"2017","unstructured":"Teshima K, Ohyagi H, Kume M, Takahashi S, Saito M, Takahashi N (2017) Refractory CD20-positive peripheral T-cell lymphoma showing loss of CD20 expression after rituximab therapy and gain of CD20 expression after administration of vorinostat and gemcitabine. Rinsho Ketsueki 58:2227\u20132231","journal-title":"Rinsho Ketsueki"},{"key":"398_CR16","first-page":"413","volume":"51","author":"DJ Li","year":"2022","unstructured":"Li DJ, Kang H, Zhang L, Xu ZG, Wang XY, Wang LF, Song XX, Kong LF (2022) Clinicopathological features of mature T\/NK cell lymphoma with aberrant CD20 or CD79\u03b1 expression. Zhonghua Bing Li Xue Za Zhi 51:413\u2013418","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"398_CR17","first-page":"1021","volume":"49","author":"SH Shao","year":"2020","unstructured":"Shao SH, Wang Y, Dai XY, Xiao YJ, Guan JJ, Lin DL, Wang JG, Li YJ, Xing XM, Zhao P (2020) CD20-positive T cell lymphoma: clinicopathological features of five cases. Zhonghua Bing Li Xue Za Zhi 49:1021\u20131026","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"398_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210095","author":"F Munir","year":"2023","unstructured":"Munir F, Hardit V, Sheikh IN, AlQahtani S, He J, Cuglievan B, Hosing C, Tewari P, Khazal S (2023) Classical Hodgkin lymphoma: from past to future-A comprehensive review of pathophysiology and therapeutic advances. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241210095","journal-title":"Int J Mol Sci"},{"key":"398_CR19","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3324\/haematol.2022.281700","volume":"108","author":"A Dogan","year":"2023","unstructured":"Dogan A (2023) The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma. Haematologica 108:1220\u20131221","journal-title":"Haematologica"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-024-00398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-024-00398-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-024-00398-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T13:07:18Z","timestamp":1730984838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-024-00398-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1007\/s00795-024-00398-9","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"type":"print","value":"1860-1480"},{"type":"electronic","value":"1860-1499"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The case report was exempted from review by the Institutional Review Board at the Yantai Yuhuangding Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The patient provided consent for the publication of his data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}